Synthesis, Photophysical Properties, and Photodynamic Therapy Efficacies of Meso-Pyridine BODIPYs and Their Ruthenium Complexes
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12310%2F25%3A43910588" target="_blank" >RIV/60076658:12310/25:43910588 - isvavai.cz</a>
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/aoc.70459?utm_source=clarivate&getft_integrator=clarivate" target="_blank" >https://onlinelibrary.wiley.com/doi/pdf/10.1002/aoc.70459?utm_source=clarivate&getft_integrator=clarivate</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/aoc.70459" target="_blank" >10.1002/aoc.70459</a>
Alternative languages
Result language
angličtina
Original language name
Synthesis, Photophysical Properties, and Photodynamic Therapy Efficacies of Meso-Pyridine BODIPYs and Their Ruthenium Complexes
Original language description
Photodynamic therapy (PDT) is a candidate approach for cancer treatment. In PDT applications, a fluorescent molecule, called photosensitizer (PS), induces light-directed production of reactive species, resulting in cytotoxicity. Having tunable fluorescence and easy derivatization properties, the BODIPY core is widely used as a PS. To further increase the light-induced toxicity, studies have shown the conjugation of heavy metals to the BODIPY core. However, such complexes are still needed to fully figure out their potential. In the current study, as part of an ongoing one, two novel ruthenium-BODIPY complexes were synthesized and characterized by structural, photophysical, and biological methods. To obtain complex structures between ruthenium dimers and BODIPY units, [RuCl2(p-cymene)](2) dimers, and non-iodo and di-iodo BODIPY derivatives were reacted in methanol-tetrahydrofuran (THF) medium. Photophysical properties, fluorescence lifetime, molar extinction coefficient, photostability, and capability of singlet oxygen generation were determined using absorption and/or fluorescence spectroscopy. Besides, the structures of the complexes were further clarified by the single-crystal X-ray technique. The cytotoxicity of compounds was examined against the human cervical cancer cell line, HeLa, and breast cancer cell line, MDA-MB-231, both in the dark and by light irradiation. Accordingly, both precursors and their ruthenium complexes were light-dependent toxic; nevertheless, di-iodinated meso-pyridine-substituted BODIPYs displayed light-independent toxicity by long-term treatments. Moreover, the effects of the complexes were cell-specific and the toxicities of di-iodinated BODIPY complexes were inversely correlated with the concentrations, underlying a possible aggregation and/or unpredicted cellular interaction pattern. These results emphasize that further functionalization and molecular characterization of BODIPY-ruthenium complexes are still required for PDT applications.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10403 - Physical chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
APPLIED ORGANOMETALLIC CHEMISTRY
ISSN
0268-2605
e-ISSN
1099-0739
Volume of the periodical
39
Issue of the periodical within the volume
12
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
nestránkováno
UT code for WoS article
001628069300021
EID of the result in the Scopus database
2-s2.0-105022282426